News

itim Group signs five-year multi-million-pound contract with Brazilian wholesaler, Assaí

itim Group plc (LON:ITIM) secures a major five-year contract with Brazil's largest wholesaler, Assaí Atacadista, to enhance pricing strategies via its UNIFY platform...

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending April 2024...

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...

DG Innovate shares AGM Results and progress on Electric Mobility projects

DG Innovate plc (LON:DGI) announces successful AGM resolution votes and shares updates on significant technical and commercial progress, including joint ventures and prototype developments...

Poolbeg Pharma relocates to new London headquarters at 40 Bank Street

Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF) has updated its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom...

Ilika ships first batch of prototype Goliath batteries to tier 1 automotive company

Ilika plc (LON:IKA) ships its first batch of Goliath prototype batteries to a tier 1 automotive company for external testing, marking a key milestone in its roadmap...

Touchstone Exploration Inc. enters into Exploration and Production Licences for the Cipero and Charuma blocks

Touchstone Exploration Inc.'s Trinidadian subsidiary, Primera Oil and Gas Limited, secures Exploration and Production Licences for Cipero and Charuma blocks, effective July 1, 2024...

hVIVO plc announce Phase 2b Influenza Field Study Contract

hVIVO to conduct a major Phase 2b field study on an influenza drug, enrolling 1,000 volunteers at its expanded Plumbers Row site, supporting future growth...

Argent BioPharma publishes Company Presentation for June 2024

Argent BioPharma Limited (ASX:RGT) has released its June 2024 Company Presentation, showcasing its innovative solutions in the biopharmaceutical sector...

Listed NB Private Equity $1.3 billion fund investment performance impresses (LON:NBPE)

NB Private Equity Partners (LON:NBPE), a $1.3bn FTSE 250 company managed by Neuberger Berman, reports a 0.6% increase in NAV to $27.50 per share for May 2024...

JSGI pays 3.4p in Q1 2024 attracting Japan income investors

JPMorgan Japan Small Cap Growth & Income plc reports a NAV of 343.60 pence per share as of June 28, 2024, and declares a 3.4p interim dividend...

European investment trends by UK investment trusts, Kepler Analysis

Kepler's research note delves into the performance of European equities, spotlighting standout companies and market dynamics, suggesting compelling investment opportunities...

Argent BioPharma secures $500,000 investment to advance drug development pipeline

Argent BioPharma (LON:RGT) raises $500,000 through a share placement at a 400% premium, boosting drug development for CannEpil® and CimetrA®...
Search

Funds

News

itim Group signs five-year multi-million-pound contract with Brazilian wholesaler, Assaí

itim Group plc (LON:ITIM) secures a major five-year contract with Brazil's largest wholesaler, Assaí Atacadista, to enhance pricing strategies via its UNIFY platform...

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending April 2024...

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...

DG Innovate shares AGM Results and progress on Electric Mobility projects

DG Innovate plc (LON:DGI) announces successful AGM resolution votes and shares updates on significant technical and commercial progress, including joint ventures and prototype developments...

Poolbeg Pharma relocates to new London headquarters at 40 Bank Street

Poolbeg Pharma plc (LON:POLB, OTCQB: POLBF) has updated its registered address to 40 Bank Street, Floor 24, London, E14 5NR, United Kingdom...

Ilika ships first batch of prototype Goliath batteries to tier 1 automotive company

Ilika plc (LON:IKA) ships its first batch of Goliath prototype batteries to a tier 1 automotive company for external testing, marking a key milestone in its roadmap...

Touchstone Exploration Inc. enters into Exploration and Production Licences for the Cipero and Charuma blocks

Touchstone Exploration Inc.'s Trinidadian subsidiary, Primera Oil and Gas Limited, secures Exploration and Production Licences for Cipero and Charuma blocks, effective July 1, 2024...

hVIVO plc announce Phase 2b Influenza Field Study Contract

hVIVO to conduct a major Phase 2b field study on an influenza drug, enrolling 1,000 volunteers at its expanded Plumbers Row site, supporting future growth...

Argent BioPharma publishes Company Presentation for June 2024

Argent BioPharma Limited (ASX:RGT) has released its June 2024 Company Presentation, showcasing its innovative solutions in the biopharmaceutical sector...

Listed NB Private Equity $1.3 billion fund investment performance impresses (LON:NBPE)

NB Private Equity Partners (LON:NBPE), a $1.3bn FTSE 250 company managed by Neuberger Berman, reports a 0.6% increase in NAV to $27.50 per share for May 2024...

JSGI pays 3.4p in Q1 2024 attracting Japan income investors

JPMorgan Japan Small Cap Growth & Income plc reports a NAV of 343.60 pence per share as of June 28, 2024, and declares a 3.4p interim dividend...

European investment trends by UK investment trusts, Kepler Analysis

Kepler's research note delves into the performance of European equities, spotlighting standout companies and market dynamics, suggesting compelling investment opportunities...

Argent BioPharma secures $500,000 investment to advance drug development pipeline

Argent BioPharma (LON:RGT) raises $500,000 through a share placement at a 400% premium, boosting drug development for CannEpil® and CimetrA®...
Search

Funds

News

FTSE 100

Funds